Lipopolymersome-mediated temozolomide delivery for IL13RA2 receptor-positive glioblastoma
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Glioma Diagnosis and Treatment · Nanoplatforms for cancer theranostics · RNA Interference and Gene Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (32)
Show source-provided references
1. Prognostic relevance and validation of ARPC1A in the progression of low-grade glioma10.18632/aging.205952 ↗
2. Role of TRPM2 in brain tumours and potential as a drug target10.1038/s41401-021-00679-4 ↗
3. Enhanced efficacy of combined temozolomide and bromodomain inhibitor therapy for gliomas using targeted nanoparticles10.1038/s41467-018-04315-4 ↗
4. Glioblastoma: pathology, molecular mechanisms and markers10.1007/s00401-015-1432-1 ↗
5. Controlled release of liposome-encapsulated temozolomide for brain tumour treatment by convection-enhanced delivery10.1080/1061186X.2017.1379526 ↗
6. Strategies increasing the effectiveness of temozolomide at various levels of anti-GBL therapy10.1016/j.biopha.2023.115174 ↗
7. In situ Engineering of Tumor-Associated Macrophages via a Nanodrug-Delivering-Drug (beta-Elemene@Stanene) Strategy for Enhanced Cancer Chemo-Immunotherapy10.1002/anie.202312436 ↗
8. Dual functionalized liposomes for efficient co-delivery of anti-cancer chemotherapeutics for the treatment of glioblastoma10.1016/j.jconrel.2019.06.033 ↗
9. S.V. Morse, A. Mishra, T.G. Chan, T.M.d.R. R, J.J. Choi, Liposome delivery to the brain with rapid short-pulses of focused ultrasound and microbubbles, J. Control Release, 341 (2022) 605-615.10.1016/j.jconrel.2021.12.005 ↗
10. A Poloxamer-407 modified liposome encapsulating epigallocatechin-3-gallate in the presence of magnesium: Characterization and protective effect against oxidative damage10.1016/j.ijpharm.2018.10.004 ↗
11. Post-insertion of poloxamer 188 strengthened liposomal membrane and reduced drug irritancy and in vivo precipitation, superior to PEGylation10.1016/j.jconrel.2015.02.026 ↗
12. Alexander, Recent advancements in liposomes targeting strategies to cross blood-brain barrier (BBB) for the treatment of Alzheimer's disease10.1016/j.jconrel.2017.05.019 ↗
13. Sriwidodo, A.K. Umar, N. Wathoni, J.H. Zothantluanga, S. Das, J.A. Luckanagul, Liposome-polymer complex for drug delivery system and vaccine stabilization, Heliyon, 8 (2022) e08934.10.1016/j.heliyon.2022.e08934 ↗
14. Combination chemotherapy via poloxamer 188 surface-modified PLGA nanoparticles that traverse the blood-brain-barrier in a glioblastoma model10.1038/s41598-024-69888-1 ↗
15. Ligand-targeted liposome design: challenges and fundamental considerations10.1016/j.tibtech.2013.09.007 ↗
16. Expression of interleukin-13 receptor alpha2 in glioblastoma multiforme: implications for targeted therapies10.1158/0008-5472.CAN-07-1493 ↗
17. Interleukin 13 receptor alpha 2 (IL13Ralpha2): Expression, signaling pathways and therapeutic applications in cancer10.1016/j.bbcan.2022.188802 ↗
18. Seek & Destroy, use of targeting peptides for cancer detection and drug delivery10.1016/j.bmc.2017.08.052 ↗
19. An interleukin 13 receptor alpha 2-specific peptide homes to human Glioblastoma multiforme xenografts10.1093/neuonc/nor141 ↗
20. IL-13Ralpha2 is a glioma-restricted receptor for interleukin-1310.1038/sj.neo.7900234 ↗
21. IL-13Ralpha2-Targeted Therapy Escapees: Biologic and Therapeutic Implications10.1593/tlo.11175 ↗
22. Peptide-based PET imaging of the tumor restricted IL13RA2 biomarker10.18632/oncotarget.16549 ↗
23. Methods and protocols of modern solid phase Peptide synthesis10.1385/MB:33:3:239 ↗
24. Reversing chemoresistance of malignant glioma stem cells using gold nanoparticles10.2147/IJN.S37481 ↗
25. Formulation and evaluation of periodontal in situ gel10.4103/2230-973X.108961 ↗
26. Nanoparticles for drug delivery: the need for precision in reporting particle size parameters10.1016/j.ejpb.2007.08.001 ↗
27. The effect of nanoparticle size on the ability to cross the blood-brain barrier: an in vivo study10.2217/nnm-2017-0022 ↗
28. Effects of particle size and surface modification on cellular uptake and biodistribution of polymeric nanoparticles for drug delivery10.1007/s11095-012-0958-3 ↗
29. Nanoparticles functionalized with Pep-1 as potential glioma targeting delivery system via interleukin 13 receptor alpha2-mediated endocytosis10.1016/j.biomaterials.2014.03.068 ↗
30. IL13RA2 targeted alpha particle therapy against glioblastomas10.18632/oncotarget.17792 ↗
31. Temozolomide: An Updated Overview of Resistance Mechanisms, Nanotechnology Advances and Clinical Applications10.2174/1570159X18666200626204005 ↗
32. Temozolomide: mechanisms of action, repair and resistance, Curr10.2174/1874467211205010102 ↗